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Introduction. Autism spectrum disorders (ASD) are a group of 
developmental  disabilities  that  affect  social  interaction, 
communication  and  are  characterized  by  repetitive  behaviors. 
There is now a large body of evidence that suggests a complex 
role  of  genetics  in  ASD,  in  which  many  different  loci  are 
involved.  Although many current  population scale  studies  have 
been  demonstrably  useful,  these  studies  generally  focus  on 
analyzing a limited part  of  the genome or use a limited set  of 
bioinformatics tools. These limitations make it difficult to see the 
complete and panoramic picture of each ASD case.  To address 
this  problem,  here  we  describe  an  integrative  bioinformatics 
pipeline used to get a more complete and reliable set of candidate 
ASD-variants for validation and further functional analysis. 	

Results.  The  resulting  set  of  candidate  variants  include  three  small 
heterozygous CNVs (~22, ~36 and ~50 Kb). All of the CNVs were only 
found  by  ERDS,  and  despite  the  fact  that  the  K21  pedigree  had 
microarray data, PennCNV did not detect any CNV in those regions. A 
heterozygous de novo  nonsense mutation in MYBBP1A  was found in 
one of the quads (K21) located within exon 1, and a second de novo 
variant was also among the final results from another quad (SSC_2), 
this time a missense mutation in LAMB3, which also has not yet been 
observed in any other ASD proband. 	

	

Having  established  a  more  comprehensive  WGS  pipeline,  we  are 
moving  to  implement  our  framework  for  the  analysis  and  study  of 
families from Utah and from the SSC . 	

 	

Figure  1.  Pedigree  structure  of  a  Simplex  Autism 
Family.  For  a  family  to  be  classified  as  a  Simplex 
Autism Family, it has to be composed of one affected 
child  and  at  least  one  unaffected  sibling,  and  both 
parents  do  not  have  obvious  autism.  Probands  and 
siblings can be either males or females. For this study, 
two of the families have male probands and unaffected 
male  siblings,  whereas  the  other  family  has  a  male 
proband and a female unaffected sibling. 	

Figure 2. Variant calling pipeline.  After aligning the genomes with BWA-MEM 0.7.5a-r405,  the 
resulting alignments were converted to binary format, then sorted and indexed using SAMtools version 
0.1.19-44428cd.  Duplicated reads were marked and read groups were assigned to  each lane using 
Picard tools v1.84. The GATK Indel realigner v3.0-0 was used to correct initial mapping artifacts due 
to reads aligning to the edges of INDELs, which often map with mismatching bases that may look like 
evidence for SNPs, while they are not. The GATK Base Quality Score Recalibrator was also used to 
correct known systematic errors of sequencing technologies. Finally all lanes were merged by sample 
with Picard tools to generate a ready-to-use alignment. Various algorithms were used to call SNPs and 
Indels, all resulting variants were filtered and prioritized with different methods. 	

Methods. We studied three simplex Autism Families, two of which belong to 
the Simon’s Simplex Collection (SSC), and all probands and families were 
clinically evaluated and extensively phenotyped. The third family, recruited 
at  the  Utah  Foundation  for  Biomedical  Research,  had  extensive  clinical 
evaluations performed, along with fragile X and Chromosomal Microarray 
Analysis  (CMA)  on  the  proband  and  mother,  with  no  obvious  disease-
contributory mutations found. All family members were genotyped using an 
Illumina  Omni2.5  Array  and/or  WGS  was  performed  using  the  Illumina 
HiSeq 2000 to ~40-75X coverage. WGS reads were aligned to the GRCh37/
hg19  human  reference  genome  using  BWA-MEM  software,  with  variant 
calling  for  SNVs  and  INDELs  using  the  GATK  HaplotypeCaller  and 
FreeBayes.  To  better  support  de  novo  calls,  we  used  Scalpel  for  INDEL 
detection and the Multinomial Analyzer. The ERDS software was used to call 
CNVs from WGS data. Microarray data were used to call CNVs with the 
software package PennCNV using the joint-calling algorithm. 	

 	

Figure 4. Copy Number Variant calling pipeline. Using the same ready to use alignment described in 
Figure 2 plus the union of variants called by Freebayes and GATK, the Estimation by Read Depth with 
Single Nucleotide Variants (ERDS) software was used to call CNVs. PennCNV was used in the samples 
where Microarray data was available and both calls sets were compared. 	

Figure 3. Algorithm concordance. GATK and Freebayes were compared as they are algorithms that 
call  both  SNVs  and  INDELs  with  a  comparable  number  of  calls.  The  intersection  grows  when 
comparing filtered SNVs and Indels. The Multinomial Analyzer and Scalpel were only used to call de 
novo SNPs and Indels respectively. 	

Figure 5c.  Genome Browser  Screen cut  for  the  Read Depths  in  the ~ 22 Kb intergenic  CNV on 
16p12.3 (Pedigree K21).	

Figure 5c. Genome Browser Screen cut for the Read Depths in the ~ 50 Kb intergenic CNV on 4p16.3 
(Pedigree SSC_2).	

Figure 5c. Genome Browser Screen cut for the Read Depths in the ~ 36 Kb intergenic CNV on 3q22.1 
(Pedigree K21).	

Figure 3a. Raw SNV	
 Figure 3b. Filtered SNV	

Figure 3c. Raw Indels	
           Figure 3d. Filtered SNV	

